To: National Focal Points (NFPs) (and Alternates) for Antimicrobial Consumption; Operational Contact Points (OCPs) for Epidemiology/TESSy Interactions - Antimicrobial Consumption (AMC)
CC: National Coordinators (Coordinating Competent Bodies)
Dear colleagues,
As mentioned in our email of 21 November 2024, the process of appointing a new Disease Network Coordination Committee (DNCC) for the European Surveillance of Antimicrobial Consumption Network (ESAC-Net), has started.
Ten (10) members of ESAC-Net have submitted their candidature to become a member of the new ESAC-Net DNCC.
As described previously, in case there is no more than ten candidates, ECDC agreed to send the names of the candidates to all NFPs and OCPs from the corresponding network asking for any major objection to the
entire proposed list of members of the DNCC.
The PROPOSED LIST OF MEMBERS OF THE ESAC-Net DNCC is as follows:
Name
|
Country
|
Functional expertise
|
Role in ESAC-Net
|
Majda Attauabi
|
Denmark
|
AMC/AMR surveillance
|
NFP (AMC)
|
Jan Baltink
|
The Netherlands
|
Pharmacy
|
NFP (AMC) alternate, OCP for epidemiology
|
Hege Salvesen Blix
|
Norway
|
AMC surveillance
|
NFP (AMC), OCP for TESSy
|
Lucy Catteau
|
Belgium
|
AMC surveillance
|
NFP (AMR, AMC) alternate, OCP for epidemiology
|
Catherine Dumartin
|
France
|
Surveillance, pharmacy
|
OCP for epidemiology
|
Emre Umut Gürpınar
|
Ireland
|
Epidemiology
|
OCP for epidemiology, microbiology, TESSy
|
Anna Olczak-Pieńkowska
|
Poland
|
AMC surveillance
|
OCP for microbiology
|
Birgitta Schweickert
|
Germany
|
Clinical microbiology and epidemiology, AMC surveillance
|
NFP (AMC) alternate, OCP for epidemiology
|
Maja Šubelj
|
Slovenia
|
Epidemiology
|
NFP (AMC), OCP for epidemiology
|
Peter Zarb
|
Malta
|
Clinical pharmacy
|
OCP for TESSy, NFP (AMC) alternate
|
If you have a major objection to the entire proposed list, please indicate so by replying to this email by Friday 31 January 2025 COB.
If no objection is received by this date, we will proceed with the appointment of the DNCC by the ECDC Director.
If you have any questions, please do not hesitate to contact us at
arhai@ecdc.europa.eu
Yours sincerely,
ECDC ARHAI Section

|
European Centre for Disease Prevention and Control (ECDC)
|
Gustav III:s boulevard 40, 169 73 Solna, Sweden
|
Phone +46 (0)8 58 60 10 00
|
www.ecdc.europa.eu
|
|
|
|
|
|
Classified as ECDC NORMAL
From:
ARHAI
Sent: 21 November 2024 13:50
To: reinhild.strauss@gesundheitsministerium.gv.at; Boudewijn.catry@sciensano.be; lucy.catteau@sciensano.be; ivanoov@gmail.com; ivanstoikovbt@gmail.com; marina.payerl-pal@zzjz-ck.hr; damjan.debelec@gmail.com; ikyriakidou@phs.moh.gov.cy; ckontemeniotou@phs.moh.gov.cy;
Lenka.Vostalova@uzis.cz; Tomas.Majek@uzis.cz; maat@ssi.dk; lau@sundhedsdata.dk; janne.sepp@ravimiamet.ee; Katrin.Kurvits@ravimiamet.ee; emmi.sarvikivi@thl.fi; tinna.voipio@fimea.fi; ghaya.benhmidene@santepubliquefrance.fr; karima.hider-mlynarz@ansm.sante.fr;
Abu-SinM@rki.de; SchweickertB@rki.de; a.maragkos@eody.gov.gr; k.mellou@eody.gov.gr; hajdu.agnes2@nngyk.gov.hu; mmatuz@gmail.com; Anna Margrét Halldórsdóttir - Landl <anna.m.halldorsdottir@landlaeknir.is>; susanna.frost@hpsc.ie; phil.downes@hpsc.ie; ARHAI@hpsc.ie;
mp.trotta@aifa.gov.it; f.fortinguerra@aifa.gov.it; Ieva.Saliete@zva.gov.lv; ieva.voita@spkc.gov.lv; andis.seilis@zva.gov.lv; esther.walser-domjan@llv.li; rolanda.valinteliene@hi.lt; martine.debacker@ms.etat.lu; stephanie.saleh@ms.etat.lu; daniel.alvarez@ms.etat.lu;
michael.a.borg@gov.mt; peter.zarb@gov.mt; Jan.Baltink@radboudumc.nl; sabine.de.greeff@rivm.nl; hege.salvesen.blix@fhi.no; a.skoczynska@nil.gov.pl; kpawlik@szpital-lebork.com.pl; a.skoczynska@nil.gov.pl; joana.fernandes@infarmed.pt; ppcira@dgs.min-saude.pt;
gabriel.popescu@umfcd.ro; roxana.serban@insp.gov.ro; tesar@fpharm.uniba.sk; Maja.Subelj@nijz.si; zoran.simonovic@nijz.si; alopezn@aemps.es; mpeinado_externo@aemps.es; andreas.sandgren@folkhalsomyndigheten.se; petra.edquist@folkhalsomyndigheten.se; alma.brolund@folkhalsomyndigheten.se;
hajdu.agnes2@nngyk.gov.hu; deptula.aleksander@gmail.com; ales.korosec@nijz.si; hoffmanna@rki.de; andis.seilis@zva.gov.lv; A.Pierantozzi@aifa.gov.it; Angela.Lehner@gesundheitsministerium.gv.at; Anna Margrét Halldórsdóttir - Landl <anna.m.halldorsdottir@landlaeknir.is>;
Anna Margrét Halldórsdóttir - Landl <anna.m.halldorsdottir@landlaeknir.is>; Anna Margrét Halldórsdóttir - Landl <anna.m.halldorsdottir@landlaeknir.is>; aolczak-pienkowska@wim.mil.pl; alopezn@aemps.es; akontemeniotis@phs.moh.gov.cy; Løvlie, Astrid Louise <Astrid.Louise.Lovlie@fhi.no>;
SchweickertB@rki.de; boyka_markova@yahoo.com; brendand@landspitali.is; carina.brehony@hpsc.ie; catherine.dumartin@chu-bordeaux.fr; ckontemeniotou@phs.moh.gov.cy; christine.hain@sozialministerium.at; c.santini@aifa.gov.it; c.santini@aifa.gov.it; cgutierrez@isciii.es;
damjan.debelec@gmail.com; David.Neumayer@bmg.gv.at; utbrudd@fhi.no; Eirik.olsen@fhi.no; ellen.mcloughlin@hpsc.ie; emmi.sarvikivi@thl.fi; umut.gurpinar@hpsc.ie; umut.gurpinar@hpsc.ie; esther.walser-domjan@llv.li; esther.walser-domjan@llv.li; esther.walser-domjan@llv.li;
esther.walser-domjan@llv.li; esther.walser-domjan@llv.li; etienne.lucas@santepubliquefrance.fr; gabriel.popescu@umfcd.ro; gabriela.elbelazi@gesundheitsministerium.gv.at; geantoniou@phs.moh.gov.cy; gerard.scheiden@ms.etat.lu; ghaya.benhmidene@santepubliquefrance.fr;
gudrun.aspelund@landlaeknir.is; hege.salvesen.blix@fhi.no; hege.salvesen.blix@fhi.no; helena.sebestova@szu.cz; ai@wido.bv.aok.de; hildigunnur.a.hall@landlaeknir.is; hildigunnur.a.hall@landlaeknir.is; Ieva.Saliete@zva.gov.lv; Ieva.Saliete@zva.gov.lv; ineta.pranskunaite@hi.lt;
ionel.iosif@insp.gov.ro; isabel.cuesta@isciii.es; iva.vlckova@szu.cz; ivanstoikovbt@gmail.com; administrator@ncipd.org; Jan.Baltink@radboudumc.nl; jana.namesna@uvzsr.sk; jan-erik.loflund@thl.fi; janne.sepp@ravimiamet.ee; j.bysiek@nil.gov.pl; Jiri.Jarkovsky@uzis.cz;
joana.fernandes@infarmed.pt; j.paulo.gomes@insa.min-saude.pt; Jorge.machado@insa.min-saude.pt; julien.durand@santepubliquefrance.fr; Katrin.Kurvits@ravimiamet.ee; kenan.ajanovic@wido.bv.aok.de; kras_ivanova@abv.bg; laura.bonacini@sciensano.be; LiveStorehagen.Dansie@fhi.no;
lucy.catteau@sciensano.be; MagnusWenstop.Ogle@fhi.no; lau@sundhedsdata.dk; lau@sundhedsdata.dk; Maja.Subelj@nijz.si; mpeinado_externo@aemps.es; mpeinado_externo@aemps.es; feigM@rki.de; Mari.Molvik@fhi.no; mjalbuquerque@dgs.min-saude.pt; mmatuz@gmail.com; mmatuz@gmail.com;
mp.trotta@aifa.gov.it; mp.trotta@aifa.gov.it; marianna.thordardottir@landlaeknir.is; marianna.thordardottir@landlaeknir.is; marie.philbin1@hse.ie; michael.a.borg@gov.mt; mpc@pzh.gov.pl; M.Roukens@akf.umcn.nl; Abu-SinM@rki.de; ppcira@dgs.min-saude.pt; ppcira@dgs.min-saude.pt;
ppcira@dgs.min-saude.pt; ppcira@dgs.min-saude.pt; olafur@landlaeknir.is; budavari.olga@nngyk.gov.hu; Pedro Licinio Pinto Leite <pedroleite@dgs.min-saude.pt>; Pedro Licinio Pinto Leite <pedroleite@dgs.min-saude.pt>; Pedro Licinio Pinto Leite <pedroleite@dgs.min-saude.pt>;
peter.zarb@gov.mt; ragda.obeid@folkhalsomyndigheten.se; ragda.obeid@folkhalsomyndigheten.se; ragnhild.raastad@fhi.no; raqueleusebio@dgs.min-saude.pt; benkoria@gmail.com; roberto.dacas@iss.it; roxana.serban@insp.gov.ro; sineadodonnell2@beaumont.ie; ssy@ssi.dk;
FuchsS@rki.de; stephanie.saleh@ms.etat.lu; Stephen.Murchan@hpsc.ie; Stephen.Murchan@hpsc.ie; susanna.frost@hpsc.ie; tanja.kustec <tanja.kustec@nijz.si>; teemu.mottonen@thl.fi; EckmannsT@rki.de; tinna.voipio@fimea.fi; tesar@fpharm.uniba.sk; SemmlerT@rki.de;
vsilvestros@ns.moh.gov.cy; viktoras.bumsteinas@nvsc.lt; w.hryniewicz@nil.gov.pl; warren.a.bruno@gov.mt; yves.dupont@sciensano.be; farkas.zsolt@nngyk.gov.hu
Cc: NC_CCB_Austria@bmg.gv.at; sigrid.kiermayr@gesundheitsministerium.gv.at; koen.blot@sciensano.be; ccb@sciensano.be; getsova@ncipd.org; iva_christova@ncipd.org; kcapak@hzjz.hr; bernard.kaic@hzjz.hr; econstantinou@moh.gov.cy; ECDC_NIPH@szu.cz; hana.orlikova@szu.cz;
kgrl@sst.dk; Suja@sst.dk; kart.sober@terviseamet.ee; julia.geller@terviseamet.ee; info@terviseamet.ee; otto.helve@thl.fi; carita.savolainen-kopra@thl.fi; Paula.garcia-lobato@santepubliquefrance.fr; anne-catherine.viso@santepubliquefrance.fr; RathmachersL@rki.de;
ecdc@rki.de; RexrothU@rki.de; anderheidenma@rki.de; t.kalomama@eody.gov.gr; d.paraskevis@eody.gov.gr; ch.chatzichristodoulou@eody.gov.gr; danielisz.agnes@nngyk.gov.hu; phc.office@nngyk.gov.hu; rezsofi.judit@nngyk.gov.hu; gudrun.aspelund@landlaeknir.is; lois.oconnor@hpsc.ie;
aine.grace@hpsc.ie; patricia.garvey@hpsc.ie; louise.cullen@hpsc.ie; lisa.domegan@hpsc.ie; f.maraglino@sanita.it; antra.bormane@spkc.gov.lv; silvia.dehler@llv.li; jurgita.pakalniskiene@sam.lt; greta.gargasiene@nvsc.lt; jurgita.pakalniskiene@sam.lt; jean-claude.schmit@ms.etat.lu;
charmaine.gauci@gov.mt; Hester.de.Melker@rivm.nl; susan.van.den.hof@rivm.nl; emilyann.macdonald@fhi.no; heidi.lange@fhi.no; kzacharczuk@pzh.gov.pl; marianaferreira@dgs.min-saude.pt; Pedro Licinio Pinto Leite <pedroleite@dgs.min-saude.pt>; cesp@dgs.min-saude.pt;
aperaltasantos@dgs.min-saude.pt; Adriana Pistol <adriana.pistol@ms.ro>; lucia.paulikova@uvzsr.sk; ecdc@uvzsr.sk; maja.socan@nijz.si; ecdcinfo@nijz.si; fsimon@sanidad.gob.es; ecdc.sweden@folkhalsomyndigheten.se; ecdc.support@folkhalsomyndigheten.se; agneta.falkfilipsson@folkhalsomyndigheten.se;
sara.bengtsson@folkhalsomyndigheten.se; Birgitta.Lesko@folkhalsomyndigheten.se; anette.richardson <anette.richardson@folkhalsomyndigheten.se>; Country Cooperation <Country.Cooperation@ecdc.europa.eu>; DPR ARHAI <DL_DPR_ARHAI@ecdc.europa.eu>
Subject: FOR ACTION - Call for candidates: Members of ESAC-Net Disease Network Coordination Committee
To: National Focal Points for Antimicrobial Consumption; Operational Contact Point for Epidemiology/TESSy Interactions - Antimicrobial Consumption (AMC)
CC: National Coordinators (Coordinating Competent Bodies)
Dear colleagues,
The mandate period for Disease Network Coordination Committee (DNCC) for the European Surveillance of Antimicrobial Consumption Network (ESAC-Net), appointed for the term February 2022 – February 2025, is coming to an end. We would like
to take the opportunity to thank ESAC-Net DNCC members who have served during this term: Majda Attauabi, Hege Salvesen Blix, Lucy Catteau, Catherine Dumartin, Maja Laursen, Stephanie Natsch, Anna Olczak-Pieńkowska, Maja
Šubelj and Peter Zarb.
It is now time to appoint a new ESAC-Net DNCC, to serve for the mandate of three years (March 2025 – February 2028). With this email, we would like to announce the
call for candidates for members of the new DNCC. The generic terms of reference for ECDC’s Disease Network Coordination Committees are attached.
According to these official generic terms of reference:
“The Disease Network Coordination Committees (DNCCs) shall support further development of the ECDC disease work and networks, by providing important but non-binding advice to respective ECDC Disease Programmes (DPs) with respect to all
aspects of its work including surveillance, prevention and control or any other technical, epidemiological or scientific aspects, thus enabling the network to improve its effectiveness and added value.”
The DNCC consists of a maximum of ten members, and it is recommended that both NFPs and OCPs are represented in the DNCC. Furthermore, according to the terms of reference, it is also recommended that the DNCC should aim for
a balance between functional expertise, gender, and geography.
If you are interested to join the ESAC-Net DNCC as a member,
please respond to this email – arhai@ecdc.europa.eu – indicating your name, role in the ECDC Competent Bodies structure (NFP or OCP), functional expertise, as well as the EU/EEA country that you represent.
Furthermore, please feel free to propose another NFP/OCP whom you would like to see as a member of the DNCC.
ECDC will then approach this person to see if they are available. If not enough volunteers come forward (or if there is a need to balance the composition of the Coordination Committee in terms of geography, gender, and expertise), ECDC may
identify and approach individuals asking for their candidacy.
The call for nominations is open until
Thursday 19th December 2024 (close of business).
ELECTION PROCEDURE
- If there are
no more than ten candidates who expressed their interest in serving on the DNCC (and there is a good balance between geography, gender, and function), ECDC will send the names of the candidates to all NFPs and OCPs asking for any major objections to
the entire proposed list of members to the DNCC.
- If there are
no major objections to the proposal as a whole, we will move forward with having the DNCC officially appointed by the ECDC Director.
- If there are
major objections to the proposal, we will arrange an electronic election, in which we will ask the NFPs to coordinate a vote yes/no (one vote per Member State) for the entire proposed list. If there is a majority support for the list, we will move forward
with having the DNCC officially appointed by the ECDC Director. If there is no majority support for the proposed list, we will start the election process over.
- If there are
more than ten candidates who expressed their interest in serving on the DNCC, we will arrange an electronic election, in which we will task the NFPs to coordinate a vote (one vote per Member State) for ten candidates from the candidates list. The ten
candidates with the most votes will be elected to the DNCC, and we will move forward with having the DNCC officially appointed by the ECDC Director.
Should you have any questions, please don’t hesitate to contact us at
arhai@ecdc.europa.eu
We look forward to receiving your candidacy for a member of the ESAC-Net DNCC!
Best regards,
ECDC Antimicrobial Resistance and Healthcare-associated Infections Section
 
|
European Centre for Disease Prevention and Control (ECDC)
|
Gustav III:s boulevard 40, 169 73 Solna, Sweden
|
Phone +46 (0)8 58 60 10 00
|
www.ecdc.europa.eu
|
|
|
|
|
|